Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217253609> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3217253609 endingPage "1023" @default.
- W3217253609 startingPage "1011" @default.
- W3217253609 abstract "COVID-19 clinical course has been quite unpredictable and efforts have been made to identify reliable markers that will help in early disease progression, prognosis and severity detection. Objective: This study thus aimed to provide evidence that will guide clinical management by reviewing studies that assessed CRP concentration and COVID-19 severity/outcome.Three electronic databases, PubMed/Medline, Google Scholar, and JSTOR were searched to identify studies available online as at 1st September 2020 which assessed COVID-19 clinical outcome and CRP concentration. The search strategy involved words combination like C-reactive protein OR inflammatory markers OR acute phase reactants and coronavirus 2019 OR ''COVID-19 OR 2019-nCoV OR SARS-CoV-2.Sixty-one articles were systematically reviewed out of 812 studies identified after duplicates were removed. The 61 studies comprised 13,891 COVID-19 patients made of 7,840 (56.4%) males and 6,051 (43.6%) females. All the papers revised were observational studies except one case-control and they cut across fifteen countries. The result of the review demonstrated that the severe cases had higher levels of C - reactive protein when compared to the mild cases in all the studies (100%). The increase in C-reactive protein was statistically significant in 78.7% of the cases.High levels of CRP are associated with COVID-19 severity.Severe cases of COVID-19 is characterized with higher CRP levels. COVID-19 cases should be screened regularly for CRP to monitor severity.L'évolution clinique du COVID-19 a été assez imprévisible et des efforts ont été faits pour identifier des marqueurs fiables qui aideront à la progression précoce de la maladie, au pronostic et à la détection de la gravité. Objectif : Cette étude visait donc à fournir des preuves qui guideront la gestion clinique en passant en revue les études qui ont évalué la concentration de CRP et la gravité/l'issue du COVID-19.Trois bases de données électroniques, PubMed/Medline, Google Scholar et JSTOR, ont été consultées pour identifier les études disponibles en ligne au 1er septembre 2020 qui évaluaient le résultat clinique du COVID-19 et la concentration de CRP. La stratégie de recherche comportait des combinaisons de mots comme protéine Créactive OU marqueurs inflammatoires OU réactifs de phase aiguë et coronavirus 2019 OU COVID-19 OU 2019-nCoV OU SARS-CoV-2.Soixante et un articles ont été systématiquement examinés sur les 812 études identifiées après suppression des doublons. Les 61 études comprenaient 13 891 patients atteints de COVID-19, dont 7 840 (56,4 %) hommes et 6 051 (43,6 %) femmes. Tous les articles examinés étaient des études d'observation, à l'exception d'un cas-témoin, et ils couvraient quinze pays. Le résultat de l'examen a démontré que les cas graves avaient des niveaux plus élevés de protéine C-réactive par rapport aux cas légers dans toutes les études (100%). L'augmentation de la protéine C-réactive était statistiquement significative dans 78,7% des cas.Des niveaux élevés de CRP sont associés à la sévérité du COVID-19.Protéine C-réactive, COVID-19, SRAS-COV-2 et Coronavirus.Les cas graves de COVID-19 sont caractérisés par des niveaux de CRP plus élevés. · Les cas de COVID-19 doivent faire l'objet d'un dépistage régulier de la CRP afin de surveiller la gravité de la maladie." @default.
- W3217253609 created "2021-12-06" @default.
- W3217253609 creator A5011994948 @default.
- W3217253609 creator A5022890337 @default.
- W3217253609 creator A5023348142 @default.
- W3217253609 creator A5049715623 @default.
- W3217253609 creator A5053752342 @default.
- W3217253609 creator A5070875479 @default.
- W3217253609 creator A5088096859 @default.
- W3217253609 creator A5088960891 @default.
- W3217253609 date "2021-10-29" @default.
- W3217253609 modified "2023-09-27" @default.
- W3217253609 title "C-Reactive Protein and Covid-19 Severity: A Systematic Review." @default.
- W3217253609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34856793" @default.
- W3217253609 hasPublicationYear "2021" @default.
- W3217253609 type Work @default.
- W3217253609 sameAs 3217253609 @default.
- W3217253609 citedByCount "7" @default.
- W3217253609 countsByYear W32172536092022 @default.
- W3217253609 countsByYear W32172536092023 @default.
- W3217253609 crossrefType "journal-article" @default.
- W3217253609 hasAuthorship W3217253609A5011994948 @default.
- W3217253609 hasAuthorship W3217253609A5022890337 @default.
- W3217253609 hasAuthorship W3217253609A5023348142 @default.
- W3217253609 hasAuthorship W3217253609A5049715623 @default.
- W3217253609 hasAuthorship W3217253609A5053752342 @default.
- W3217253609 hasAuthorship W3217253609A5070875479 @default.
- W3217253609 hasAuthorship W3217253609A5088096859 @default.
- W3217253609 hasAuthorship W3217253609A5088960891 @default.
- W3217253609 hasConcept C116675565 @default.
- W3217253609 hasConcept C126322002 @default.
- W3217253609 hasConcept C142724271 @default.
- W3217253609 hasConcept C17744445 @default.
- W3217253609 hasConcept C177713679 @default.
- W3217253609 hasConcept C199539241 @default.
- W3217253609 hasConcept C23131810 @default.
- W3217253609 hasConcept C2776914184 @default.
- W3217253609 hasConcept C2779134260 @default.
- W3217253609 hasConcept C2779473830 @default.
- W3217253609 hasConcept C2781195455 @default.
- W3217253609 hasConcept C30036603 @default.
- W3217253609 hasConcept C3006700255 @default.
- W3217253609 hasConcept C3007834351 @default.
- W3217253609 hasConcept C3008058167 @default.
- W3217253609 hasConcept C524204448 @default.
- W3217253609 hasConcept C71924100 @default.
- W3217253609 hasConceptScore W3217253609C116675565 @default.
- W3217253609 hasConceptScore W3217253609C126322002 @default.
- W3217253609 hasConceptScore W3217253609C142724271 @default.
- W3217253609 hasConceptScore W3217253609C17744445 @default.
- W3217253609 hasConceptScore W3217253609C177713679 @default.
- W3217253609 hasConceptScore W3217253609C199539241 @default.
- W3217253609 hasConceptScore W3217253609C23131810 @default.
- W3217253609 hasConceptScore W3217253609C2776914184 @default.
- W3217253609 hasConceptScore W3217253609C2779134260 @default.
- W3217253609 hasConceptScore W3217253609C2779473830 @default.
- W3217253609 hasConceptScore W3217253609C2781195455 @default.
- W3217253609 hasConceptScore W3217253609C30036603 @default.
- W3217253609 hasConceptScore W3217253609C3006700255 @default.
- W3217253609 hasConceptScore W3217253609C3007834351 @default.
- W3217253609 hasConceptScore W3217253609C3008058167 @default.
- W3217253609 hasConceptScore W3217253609C524204448 @default.
- W3217253609 hasConceptScore W3217253609C71924100 @default.
- W3217253609 hasIssue "10" @default.
- W3217253609 hasLocation W32172536091 @default.
- W3217253609 hasOpenAccess W3217253609 @default.
- W3217253609 hasPrimaryLocation W32172536091 @default.
- W3217253609 hasRelatedWork W13479124 @default.
- W3217253609 hasRelatedWork W15403295 @default.
- W3217253609 hasRelatedWork W17252258 @default.
- W3217253609 hasRelatedWork W17271954 @default.
- W3217253609 hasRelatedWork W18579612 @default.
- W3217253609 hasRelatedWork W20205185 @default.
- W3217253609 hasRelatedWork W5105715 @default.
- W3217253609 hasRelatedWork W5235073 @default.
- W3217253609 hasRelatedWork W6663992 @default.
- W3217253609 hasRelatedWork W8356062 @default.
- W3217253609 hasVolume "Vol. 38" @default.
- W3217253609 isParatext "false" @default.
- W3217253609 isRetracted "false" @default.
- W3217253609 magId "3217253609" @default.
- W3217253609 workType "article" @default.